ArticleBMJ open diabetes research & care2020
Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
Article in BMJ open diabetes research & care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 46 citations in OpenAlex.
- Cardiovascular outcomes of empagliflozin-GLP-1RA combination therapy in type 2 diabetes: EMPRISE study.Cardiovascular diabetology · 2026Article
- Patterns of complication burden in people with diabetes: a latent class analysis approach.Acta diabetologica · 2026Article
- Review
- Potential overtreatment in elderly patients with diabetes mellitus: Results from a cross-sectional study in German general practice.The European journal of general practice · 2025Article
- The impact of learning disabilities on control, management, and outcomes of type 2 diabetes mellitus in the UK: an observational cohort study using the Clinical Practice Research Datalink.BMJ open diabetes research & care · 2025Observational
- Risk of poor glycemic control in tamsulosin versus finasteride users with type 2 diabetes mellitus.Heliyon · 2025Article
- Multimorbidity in elderly patients with or without T2DM: A real-world cross-sectional analysis based on primary care and hospitalisation data.Journal of global health · 2024Article
- Management of older adults with diabetes mellitus: Perspective from geriatric medicine.Journal of diabetes investigation · 2024Review
- Determinants of health-related quality of life of patients with type 2 diabetes and multimorbidity: a cross-sectional study.Hormones (Athens, Greece) · 2024Article
- Exploring the self-efficacy of patients with diabetes: its role as a predictor of diabetes management and well-being.Frontiers in endocrinology · 2024Article
- Glycemic control and associated factors among type 2 diabetes mellitus patients: a cross-sectional study of Azar cohort population.BMC endocrine disorders · 2023Article
- Glucagon fill rates and cost among children and adolescents with type 1 diabetes in the United States, 2011-2021.Diabetes research and clinical practice · 2023Article
- Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023Article
- Multimorbidity, Polypharmacy, Severe Hypoglycemia, and Glycemic Control in Patients Using Glucose-Lowering Drugs for Type 2 Diabetes: A Retrospective Cohort Study Using Health Insurance Claims in Japan.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023Article
- Diabetes Medication Changes in Older Adults With Type 2 Diabetes: Insights Into Physician Factors and Questions Ahead.Diabetes care · 2023Article
- Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease.JAMA network open · 2023Article
- All-cause mortality after hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011-2020.Diabetes research and clinical practice · 2023Article
- Multimorbidity, Frailty and Diabetes in Older People-Identifying Interrelationships and Outcomes.Journal of personalized medicine · 2022Review
- Article
- Potential Risk of Overtreatment in Patients with Type 2 Diabetes Aged 75 Years or Older: Data from a Population Database in Catalonia, Spain.Journal of clinical medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
Abstract
introductionGlycemic targets and glucose-lowering regimens should be individualized based on multiple factors, including the presence of comorbidities. We examined contemporary patterns of glycemic control and use of medications known to cause hypoglycemia among adults with diabetes across age and multimorbidity. RESEARCH DESIGN AND
methodsWe retrospectively examined glycosylated hemoglobin (HbA
resultsAmong 194 157 patients with type 2 diabetes included in the study, 45.2% had only concordant comorbidities, 30.6% concordant and discordant, 2.7% only discordant, and 13.0% had ≥1 advanced comorbidity. Mean HbA
conclusionsThe proportion of patients achieving low HbA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.